AME Stock: Price, Forecast, Financials & AI Analysis

High

Open

VWAP

Vol

Mkt Cap

Low

Amount

EV/EBITDA(TTM)

Total Shares

EV/OCF(TTM)

P/S(TTM)

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2025Q4

FY2026Q1

FY2026Q2

1.94B

+10.38%

1.940

+3.74%

1.91B

+10.04%

1.893

+8.16%

1.96B

+10.05%

1.953

+9.74%

Estimates Revision

The market is revising Upward the revenue expectations for AMETEK, Inc. (AME) for FY2025, with the revenue forecasts being adjusted by 1.2% over the past three months. During the same period, the stock price has changed by 7.75%.

Revenue Estimates for FY2025

Revise Upward

+1.2%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+2.43%

In Past 3 Month

Stock Price

Go Up

+7.75%

In Past 3 Month

8 Analyst Rating

Wall Street analysts forecast AME stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AME is 220.71 USD with a low forecast of 180.00 USD and a high forecast of 246.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

6 Buy

2 Hold

0 Sell

Strong Buy

Current: 201.780

Low

180.00

Averages

220.71

High

246.00

Current: 201.780

Low

180.00

Averages

220.71

High

246.00

BofA

BofA analysts

renew

2025-12-09

Reason

BofA

BofA analysts

Price Target

2025-12-09

renew

Reason

BofA analysts are adding PSEG (PEG) to the firm's "US 1 List" and renewing Walmart (WMT) and Ametek (AME) after 52 weeks on the list, which represents a collection of the firm's analysts' best investment ideas among Buy-rated, U.S.-listed stocks.

DA Davidson

Buy

maintain

$235 -> $240

2025-12-08

Reason

DA Davidson

Price Target

$235 -> $240

2025-12-08

maintain

Buy

Reason

DA Davidson raised the firm's price target on Ametek to $240 from $235 and keeps a Buy rating on the shares after meeting with its CEO. The firm has come away incrementally optimistic regarding the company's organic growth and margin prospects heading into 2026, led by potential incremental strengthening in its Process and Power verticals, complimented by a resurgence of secularly-led growth within its medical and automation businesses alongside robust growth within A&D, the analyst tells investors in a research note.

Baird

Richard Eastman

upgrade

$198 -> $204

2025-11-03

Reason

Baird

Richard Eastman

Price Target

$198 -> $204

2025-11-03

upgrade

Reason

Baird analyst Richard Eastman raised the firm's price target on Ametek to $204 from $198. The firm updated its model following Q3 results where the earnings beat was a welcome sign as demand uplifts orders.

Truist

Buy

maintain

$229 -> $246

2025-11-02

Reason

Truist

Price Target

$229 -> $246

2025-11-02

maintain

Buy

Reason

Truist raised the firm's price target on Ametek to $246 from $229 and keeps a Buy rating on the shares after its Q3 beat on better sales, margins, and adjusted EPS. By segment, EMG - Electromechanical Group - had an exceptional quarter, with total sales up 13% y/y and organic sales up 12% y/y, with growth seen as broad-based across all EMG businesses in Q3, the analyst tells investors in a research note.

KeyBanc

Overweight

maintain

$205 -> $220

2025-10-31

Reason

KeyBanc

Price Target

$205 -> $220

2025-10-31

maintain

Overweight

Reason

KeyBanc raised the firm's price target on Ametek to $220 from $205 and keeps an Overweight rating on the shares. The firm notes shares were up on Q3 results and commentary indicating strong second half of 2025 momentum underscored by broad-based end-market improvement.

RBC Capital

Deane Dray

Outperform

maintain

$212 -> $229

2025-10-31

Reason

RBC Capital

Deane Dray

Price Target

$212 -> $229

2025-10-31

maintain

Outperform

Reason

RBC Capital analyst Deane Dray raised the firm's price target on Ametek to $229 from $212 and keeps an Outperform rating on the shares after its Q3 earnings beat. Good earnings quality was evident in the company's 4% organic growth and seasonally solid 113% free cash flow, the analyst tells investors in a research note.

Valuation Metrics

The current forward P/E ratio for AMETEK Inc (AME.N) is 26.01, compared to its 5-year average forward P/E of 24.39. For a more detailed relative valuation and DCF analysis to assess AMETEK Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

5Y Average PE

24.39

Current PE

26.01

Overvalued PE

26.37

Undervalued PE

22.41

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

18.41

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

19.76

Undervalued EV/EBITDA

17.06

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

5.27

Current PS

0.00

Overvalued PS

5.73

Undervalued PS

4.82

Financials

Annual

Quarterly

N/A

Total Revenue

N/A

Operating Profit

N/A

Net Income after Tax

N/A

EPS - Diluted

N/A

Free Cash Flow

N/A

Gross Profit Margin - %

N/A

FCF Margin - %

N/A

Net Margin - %

N/A

ROIC

Trading Trends

Insider

Insiders areSelling! The selling amount has increased 238.88% over the last month.

Sold

Bought

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

Bought

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

Bought

Insider

Insiders areSelling! The selling amount has increased 238.88% over the last month.

Sold

Bought

AME News & Events

Events Timeline

No data

News

6.5

12-04CNBC

Collective Insight: Josh Brown Highlights the Market's Unique Signal for This Stock

4.0

11-25NASDAQ.COM

Ametek (AME) Receives Upgrade to Buy: Key Information You Need to Know

4.5

11-11PRnewswire

AMETEK Releases 2025 Sustainability Report

People Also Watch

Frequently Asked Questions

What is AMETEK Inc (AME) stock price today?

The current price of AME is 201.78 USD — it has decreased -0.69 % in the last trading day.

What is AMETEK Inc (AME)'s business?

AMETEK, Inc. is a global provider of industrial technology solutions serving a diverse set of niche markets. The Company's segments include Electronic Instruments Group (EIG) and Electromechanical Group (EMG). EIG segment designs and manufactures advanced analytical, test and measurement instruments for the process, aerospace, medical, research, power and industrial markets. It provides a range of instruments to the research and laboratory equipment, ultra-precision manufacturing, optics, medical, and test and measurement markets. It also provides three-dimensional measurement and imaging solutions, including portable measurement arms, laser scanners and trackers, software solutions, and comprehensive service offerings. EMG designs and manufactures engineered medical components and devices, automation solutions, thermal management systems, specialty metals and electrical interconnects. It supplies powdered metals, strip and foil, specialty clad metals and metal matrix composites.

What is the price predicton of AME Stock?

What is AMETEK Inc (AME)'s revenue for the last quarter?

AMETEK Inc revenue for the last quarter amounts to 1.89B USD, increased 10.77 % YoY.

What is AMETEK Inc (AME)'s earnings per share (EPS) for the last quarter?

AMETEK Inc. EPS for the last quarter amounts to 1.60 USD, increased 8.84 % YoY.

What changes have occurred in the market's expectations for AMETEK Inc (AME)'s fundamentals?

How many employees does AMETEK Inc (AME). have?

AMETEK Inc (AME) has 21500 emplpoyees as of December 17 2025.

What is AMETEK Inc (AME) market cap?

Today AME has the market capitalization of 46.45B USD.